Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A five-year retrospective cohort analysis of 160,752 patients
{{output}}
Objectives: This study investigated the neuroprotective effects of sodium-glucose cotransporter-2 inhibitor (SGLT2i) in reducing dementia risk among older adults with type 2 diabetes mellitus (T2DM), compared to dipeptidyl peptid... ...
